Last December, a group of scientists at a biotech firm published a paper on a “miniaturized, robotic clinical laboratory.” The technique, according to the authors, “would benefit patients and physicians alike.” Nothing terribly unusual there. But what was — and what caught the eye of a Retraction Watch reader — was the name of the … Continue reading What should happen to a paper published by Theranos?